Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Neumologia | EligiMed
Ensayos clinicos
898 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
INTERVENTIONAL
Inicio: 20 de ene de 2021
ID: NCT04084678
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)
INTERVENTIONAL
Inicio: 23 de jul de 2019
ID: NCT03979313
Terminado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Randomized, Double-blind, Double-dummy, Parallel-group, Placebo-controlled Study of Fevipiprant Once Daily Plus Standard-of-care (SoC) for Reduction of Systemic Corticosteroids (Oral and Parenteral) Use in Patients With Severe Asthma
INTERVENTIONAL
Inicio: 13 de dic de 2018
ID: NCT03629249
Completado
Fase 3
ClinicalTrials.gov
A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332/RITONAVIR IN PREVENTING SYMPTOMATIC SARS-COV-2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID-19
INTERVENTIONAL
Inicio: 9 de sept de 2021
ID: NCT05047601
Terminado
Fase 3
ClinicalTrials.gov
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
INTERVENTIONAL
Inicio: 2 de dic de 2021
ID: NCT05036135
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, 52-week, Double-blind, Parallelgroup, Active Controlled Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
INTERVENTIONAL
Inicio: 8 de dic de 2015
ID: NCT02571777
Terminado
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Canakinumab Versus Placebo as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II -IIIA and IIIB (T>5cm N2) Completely Resected (R0) Non-small Cell Lung Cancer (NSCLC)
INTERVENTIONAL
Inicio: 16 de mar de 2018
ID: NCT03447769
Completado
Fase 3
ClinicalTrials.gov
AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 2/3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF-07321332/RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID-19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS
INTERVENTIONAL
Inicio: 16 de jul de 2021
ID: NCT04960202
Activo, no recluta
Fase 3
ClinicalTrials.gov
A PHASE 3 STUDY TO EVALUATE THE EFFICACY, IMMUNOGENICITY, AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN ADULTS
INTERVENTIONAL
Inicio: 31 de ago de 2021
ID: NCT05035212
Completado
Fase 2
ClinicalTrials.gov
A Phase 2B, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once-Daily Orally Administered PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium Bromide
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01543919
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
INTERVENTIONAL
Inicio: 4 de oct de 2022
ID: NCT05255991
Completado
Fase 3
ClinicalTrials.gov
A PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY
INTERVENTIONAL
Inicio: 17 de jun de 2020
ID: NCT04424316
Completado
Fase 1
ClinicalTrials.gov
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Combination Vaccine Candidates in Older Adults
INTERVENTIONAL
Inicio: 9 de mar de 2023
ID: NCT05788237
Completado
Fase 3
ClinicalTrials.gov
A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults ≥60 Years of Age
INTERVENTIONAL
Inicio: 17 de nov de 2021
ID: NCT05127434
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults With Uncontrolled Asthma at Risk of Exacerbations (LEVANTE)
INTERVENTIONAL
Inicio: 30 de ago de 2024
ID: NCT06529419
Terminado
Fase 3
ClinicalTrials.gov
A 2-treatment Period, Randomized, Placebo-controlled, Multicenter Parallel-group Study to Assess the Safety of QAW039 When Added to Existing Asthma Therapy in GINA Steps 3, 4 and 5 Patients With Uncontrolled Asthma.
INTERVENTIONAL
Inicio: 21 de mar de 2017
ID: NCT03052517
Completado
Fase 2
ClinicalTrials.gov
A PHASE 2B, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN 18 THROUGH 49 YEARS OF AGE AND THEIR INFANTS
INTERVENTIONAL
Inicio: 7 de ago de 2019
ID: NCT04032093
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Investigate the Safety, Tolerability, and Immunogenicity of Revaccinating Pregnant Participants During Subsequent Pregnancies and Persistence of Immunity of a Single Dose of a Bivalent Respiratory Syncytial Virus (RSV) Vaccine.
INTERVENTIONAL
Inicio: 16 de abr de 2025
ID: NCT06866405
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Active-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Ramipril on Morbidity and Mortality in High Risk Patients Following an Acute Myocardial Infarction (AMI)
INTERVENTIONAL
Inicio: 9 de dic de 2016
ID: NCT02924727
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
INTERVENTIONAL
Inicio: 25 de nov de 2022
ID: NCT05629962
Anterior
1
2
3
...
45
Siguiente
Filtros